Jakub Fronczek

Also affiliated with AstraZeneca (Spain)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Remdesivir use in patients with coronavirus COVID-19 disease: a systematic review and meta-analysis of the Chinese Lancet trial with the NIH trial”.

Remdesivir use in patients with coronavirus COVID-19 disease: a systematic review and meta-analysis of the Chinese Lancet trial with the NIH trial

10.1101/2020.05.23.20110932

N/A

0.877DataRank · unranked

13 citations

Joshua Piticaru, Kimberley Lewis, Komal Aryal, Priya Thomas, Wojciech Szczeklik +5 more

Academic anaesthesiology: a global perspective on training, support, and future development of early career researchers

British Journal of Anaesthesia(2023)10.1016/j.bja.2023.07.030

N/A

0DataRank · unranked

15 citations

Meredith C B Adams, Jakub Fronczek, Vikas Kaura, Li Li, Megan Allen +2 more